Manufacturer record

Ethicare Pharmaceuticals (P) Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by Ethicare Pharmaceuticals (P) Ltd (Gujarat) were declared Not of Standard Quality in October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: ADN5001, Buprenorphine and Naloxone Sublingual Tablets IP (Adnomore-N) (exp Feb 2028). SDTL, Punjab (state lab) found it not of standard quality: Content. Listed in the October 2025 alert.

Records by type

5 records linked to Ethicare Pharmaceuticals (P) Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Oct 2025 to Oct 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2025
1
Products affected
Other
Most common failure
Oct 2025
Latest alert

Flagged batches per year

2025 · 5

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Buprenorphine and Naloxone Sublingual Tablets IP (Adnomore-N) Batch ADN5001Mfg Apr 2025 · Exp Feb 2028 ContentOther SDTL, PunjabState lab Oct 2025
Buprenorphine and Naloxone Sublingual Tablets IP (Adnomore-N) Batch ADL5001Mfg Jun 2025 · Exp May 2028 ContentOther SDTL, PunjabState lab Oct 2025
Buprenorphine and Naloxone Sublingual Tablets IP Batch ATN5006Mfg Jul 2025 · Exp Jun 2028 ContentOther SDTL, PunjabState lab Oct 2025
Buprenorphine and Naloxone Sublingual Tablets IP Batch ATN4007Mfg Aug 2024 · Exp Jul 2027 ContentOther SDTL, PunjabState lab Oct 2025
Buprenorphine and Naloxone Sublingual Tablets IP Batch ATL4001Mfg Mar 2024 · Exp Feb 2027 ContentOther SDTL, PunjabState lab Oct 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.